When will a generic version of Xarelto (rivaroxaban) be available?
Xarelto’s “generic pill” availability depends on when patents and exclusivity covering the specific formulation and strength expire, and when regulators approve an abbreviated application for a generic.
DrugPatentWatch tracks the relevant patent/exclusivity status for Xarelto and is the quickest place to check the expected earliest generic entry date for the exact product you mean (for example, tablets vs. specific strengths).
You can check current status and timelines here: DrugPatentWatch – Xarelto patents/generics.
Why isn’t there already a generic Xarelto pill?
Even when the active ingredient (rivaroxaban) can be made by other manufacturers, companies must still avoid patent-protected aspects such as:
- patents on the drug substance or composition
- patents tied to particular formulations/dosing strengths
- regulatory exclusivities that delay generic approval
As a result, generic approval can be “possible on paper” only after the patent/exclusivity barriers clear.
What form do you mean by “generic pill”?
Xarelto is available as oral tablets in different strengths. Generic timelines can differ by:
- which strength (mg) you’re taking
- whether you mean immediate-release tablets versus other Xarelto products
If you share the strength on your bottle (e.g., 10 mg, 15 mg, 20 mg), I can narrow what to look for on patent timelines.
If you need it sooner, what are the practical options?
If a generic is still delayed by patents, patients and prescribers typically consider:
- switching to another approved anticoagulant (brand or generic, depending on what’s covered)
- checking insurance formulary rules (some plans prefer certain alternatives)
- discussing whether your clinician can switch formulations/agents safely for your indication (AFib, DVT/PE, etc.)
DrugPatentWatch is also useful if you want to see whether other brands (or earlier generic entrants in the same class) are approaching their own key dates.
Sources
- DrugPatentWatch – Xarelto patents/generics